Abstract
Genital tract infections and cytokine perturbations are associated with increased HIV acquisition and transmission. We measured the relationship between bacterial vaginosis (BV) and concentrations of Interleukin-8 (IL-8), Interleukin-1
Genital tract infections and cytokine perturbations are associated with increased HIV acquisition and transmission. We measured the relationship between bacterial vaginosis (BV) and concentrations of Interleukin-8 (IL-8), Interleukin-1
H. L. Martin Jr., B. A. Richardson, P. M. Nyange et al., “Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition,” The Journal of Infectious Diseases, vol. 180, no. 6, pp. 1863–1868, 1999.
View at: Publisher Site | Google ScholarS. Cu-Uvin, J. W. Hogan, A. M. Caliendo et al., “Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract,” Clinical Infectious Diseases, vol. 33, no. 6, pp. 894–896, 2001.
View at: Publisher Site | Google ScholarB. E. Sha, M. R. Zariffard, Q. J. Wang et al., “Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis,” The Journal of Infectious Diseases, vol. 191, no. 1, pp. 25–32, 2005.
View at: Publisher Site | Google ScholarL. Al-Harthi, K. A. Roebuck, G. G. Olinger et al., “Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 21, no. 3, pp. 194–202, 1999.
View at: Google ScholarS. S. Witkin, I. M. Linhares, P. Giraldo, and W. J. Ledger, “An altered immunity hypothesis for the development of symptomatic bacterial vaginosis,” Clinical Infectious Diseases, vol. 44, no. 4, pp. 554–557, 2007.
View at: Publisher Site | Google ScholarM. Alfano and G. Poli, “The cytokine network in HIV infection,” Current Molecular Medicine, vol. 2, no. 8, pp. 677–689, 2002.
View at: Publisher Site | Google ScholarB. R. Lane, K. Lore, P. J. Bock et al., “Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy,” Journal of Virology, vol. 75, no. 17, pp. 8195–8202, 2001.
View at: Publisher Site | Google ScholarR. Narimatsu, D. Wolday, and B. K. Patterson, “IL-8 increases transmission of HIV type 1 in cervical explant tissue,” AIDS Research and Human Retroviruses, vol. 21, no. 3, pp. 228–233, 2005.
View at: Publisher Site | Google ScholarK. Sturm-Ramirez, A. Gaye-Diallo, G. Eisen, S. Mboup, and P. J. Kanki, “High levels of tumor necrosis factor- and interleukin-1 in bacterial vaginosis may increase susceptibility to human immunodeficiency virus,” The Journal of Infectious Diseases, vol. 182, no. 2, pp. 467–473, 2000.
View at: Publisher Site | Google ScholarS. R. Hedges, F. Barrientes, R. A. Desmond, and J. R. Schwebke, “Local and systemic cytokine levels in relation to changes in vaginal flora,” The Journal of Infectious Diseases, vol. 193, no. 4, pp. 556–562, 2006.
View at: Publisher Site | Google ScholarM. H. Yudin, D. V. Landers, L. Meyn, and S. L. Hillier, “Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial,” Obstetrics & Gynecology, vol. 102, no. 3, pp. 527–534, 2003.
View at: Publisher Site | Google ScholarS. Cauci, S. Guaschino, D. de Aloysio et al., “Interrelationships of interleukin-8 with interleukin-1 and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women,” Molecular Human Reproduction, vol. 9, no. 1, pp. 53–58, 2003.
View at: Google ScholarR. B. Ness, S. Hillier, H. E. Richter et al., “Can known risk factors explain racial differences in the occurrence of bacterial vaginosis?” Journal of the National Medical Association, vol. 95, no. 3, pp. 201–212, 2003.
View at: Google ScholarD. K. Smith, D. L. Warren, D. Vlahov et al., “Design and baseline participant characteristics of the human immunodeficiency virus epidemiology research (HER) study: a prospective cohort study of human immunodeficiency virus infection in US women,” American Journal of Epidemiology, vol. 146, no. 6, pp. 459–469, 1997.
View at: Google ScholarG. F. Reed, B. D. Meade, and M. C. Steinhoff, “The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data,” Pediatrics, vol. 96, no. 3, part 2, pp. 600–603, 1995.
View at: Google ScholarA. Spinillo, M. Debiaggi, F. Zara, R. Maserati, F. Polatti, and A. De Santolo, “Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions,” British Journal of Obstetrics and Gynaecology, vol. 108, no. 6, pp. 634–641, 2001.
View at: Publisher Site | Google ScholarR. Fichorova, P. J. Desai, F. C. Gibson III, and C. A. Genco, “Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells,” Infection and Immunity, vol. 69, no. 9, pp. 5840–5848, 2001.
View at: Publisher Site | Google ScholarS. Zhang, D. J. Wear, and S.-C. Lo, “Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells,” FEMS Immunology & Medical Microbiology, vol. 27, no. 1, pp. 43–50, 2000.
View at: Publisher Site | Google ScholarD. N. Fredricks, T. L. Fiedler, and J. M. Marrazzo, “Molecular identification of bacteria associated with bacterial vaginosis,” The New England Journal of Medicine, vol. 353, no. 18, pp. 1899–1911, 2005.
View at: Publisher Site | Google ScholarB. E. Sha, R. D. D'Amico, A. L. Landay et al., “Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 16, no. 3, pp. 161–168, 1997.
View at: Google Scholar